• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人工智能医疗机构中的尿微量白蛋白检测糖尿病早期肾损伤的价值分析。

Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes.

机构信息

Department of Endocrinology, Affiliated Hospital of Beihua University, Jilin 132012, China.

出版信息

J Healthc Eng. 2021 Mar 12;2021:6678454. doi: 10.1155/2021/6678454. eCollection 2021.

DOI:10.1155/2021/6678454
PMID:33777345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979295/
Abstract

As the scale and depth of artificial intelligence network models continue to increase, their accuracy in albumin recognition tasks has increased rapidly. However, today's small medical datasets are the main reason for the poor recognition of artificial intelligence techniques in this area. The sample size in this article is based on the data analysis and research on urine albumin detection of diabetes in the EI database. It is assumed that the observation group has at least 20 mg UAER difference from the control group, and the standard deviation of the UAER change from baseline to 12 weeks is 30 mg. Therefore, the sample size of the two groups is 77 cases. Assuming that the rate of loss to follow-up during the follow-up period is 20%, at least 92 patients are needed. The final enrollment in this study is 100 patients. Studies have shown that DR is used as an indicator to diagnose NDRD, and its OR value is as high as 28.198, indicating that non-DR can be used as an indicator to distinguish DN from NDRD. The meta-analysis found that DR has a sensitivity of 0.65 and a specificity of 0.75 in distinguishing DN from NDRD in patients with type 2 diabetes, and it is emphasized that PDR is highly specific in the diagnosis of DN. Using a meta-analysis to systematically analyze 45 studies, it was found that the sensitivity of DR to diagnose DN was 0.67, the specificity was 0.78, and the specificity of PDR to predict DN was 0.99, indicating that DR is a good indicator for predicting DN, and the team's latest research has also verified this point of view. They have established a new model for diagnosing DN. In addition to including traditional proteinuria, glycosylated hemoglobin, FR, blood pressure, and other indicators into the diagnostic model, it will also include the presence or absence of DR. The final external verification accuracy rate of this model is 0.875.

摘要

随着人工智能网络模型的规模和深度不断增加,其在白蛋白识别任务中的准确性迅速提高。然而,目前的小医学数据集是人工智能技术在这一领域识别能力较差的主要原因。本文的样本量基于 EI 数据库中糖尿病尿白蛋白检测的数据分析和研究。假设观察组与对照组的 UAER 差异至少为 20mg,并且从基线到 12 周 UAER 变化的标准差为 30mg。因此,两组的样本量为 77 例。假设在随访期间失访率为 20%,则至少需要 92 例患者。本研究最终共纳入 100 例患者。研究表明,DR 作为 NDRD 的诊断指标,其 OR 值高达 28.198,提示非 DR 可作为鉴别 DN 与 NDRD 的指标。荟萃分析发现,DR 在鉴别 2 型糖尿病患者 DN 与 NDRD 时的灵敏度为 0.65,特异性为 0.75,强调 PDR 在 DN 的诊断中具有高度特异性。采用荟萃分析系统分析 45 项研究发现,DR 诊断 DN 的灵敏度为 0.67,特异性为 0.78,PDR 预测 DN 的特异性为 0.99,提示 DR 是预测 DN 的良好指标,研究团队的最新研究也验证了这一观点。他们建立了一种新的诊断 DN 的模型。除了将传统的蛋白尿、糖化血红蛋白、FR、血压等指标纳入诊断模型外,还将 DR 的有无纳入其中。该模型的最终外部验证准确率为 0.875。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/cbab7cc03550/JHE2021-6678454.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/4702067a6b3a/JHE2021-6678454.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/af3effc2425d/JHE2021-6678454.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/f633a630a668/JHE2021-6678454.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/72f3a236400c/JHE2021-6678454.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/0c1c606c62c3/JHE2021-6678454.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/4226a3e273b7/JHE2021-6678454.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/9aca00c3ee10/JHE2021-6678454.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/172429914d6d/JHE2021-6678454.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/cbab7cc03550/JHE2021-6678454.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/4702067a6b3a/JHE2021-6678454.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/af3effc2425d/JHE2021-6678454.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/f633a630a668/JHE2021-6678454.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/72f3a236400c/JHE2021-6678454.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/0c1c606c62c3/JHE2021-6678454.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/4226a3e273b7/JHE2021-6678454.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/9aca00c3ee10/JHE2021-6678454.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/172429914d6d/JHE2021-6678454.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be7/7979295/cbab7cc03550/JHE2021-6678454.009.jpg

相似文献

1
Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes.利用人工智能医疗机构中的尿微量白蛋白检测糖尿病早期肾损伤的价值分析。
J Healthc Eng. 2021 Mar 12;2021:6678454. doi: 10.1155/2021/6678454. eCollection 2021.
2
Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis.鉴别 2 型糖尿病患者中非糖尿病性肾脏疾病与糖尿病肾病的参数:一项荟萃分析。
PLoS One. 2013 May 14;8(5):e64184. doi: 10.1371/journal.pone.0064184. Print 2013.
3
Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.中国东北某医疗中心2型糖尿病患者非糖尿病性肾脏疾病的临床病理特征:273例回顾性分析
Int Urol Nephrol. 2016 Oct;48(10):1691-8. doi: 10.1007/s11255-016-1331-y. Epub 2016 Jun 6.
4
Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.在大量2型糖尿病患者中区分非糖尿病性肾脏疾病与糖尿病肾病的临床预测因素。
Diabetes Res Clin Pract. 2016 Nov;121:112-118. doi: 10.1016/j.diabres.2016.09.005. Epub 2016 Sep 21.
5
Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients.设计和验证 2 型糖尿病患者糖尿病肾病与非糖尿病肾脏疾病鉴别诊断的评分模型。
J Diabetes. 2020 Mar;12(3):237-246. doi: 10.1111/1753-0407.12994. Epub 2019 Dec 2.
6
A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases.糖尿病肾病与非糖尿病性肾脏疾病的鉴别诊断模型。
Nephrol Dial Transplant. 2008 Jun;23(6):1940-5. doi: 10.1093/ndt/gfm897. Epub 2007 Dec 21.
7
Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.基于非依赖性采集蛋白质组学的用于诊断糖尿病肾病的尿液外泌体无创生物标志物的鉴定。
Int J Mol Sci. 2023 Sep 1;24(17):13560. doi: 10.3390/ijms241713560.
8
Predictors and histopathological characteristics of non-diabetic renal disorders in diabetes: a look from the tubulointerstitial point of view.糖尿病患者中非糖尿病性肾脏疾病的预测因子和组织病理学特征:从肾小管间质性角度观察。
Intern Med J. 2019 Dec;49(12):1524-1533. doi: 10.1111/imj.14334.
9
[Validation and comparison of diabetic retinopathy-based diagnostic models for diabetic nephropathy].[基于糖尿病视网膜病变的糖尿病肾病诊断模型的验证与比较]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Sep 20;43(9):1585-1590. doi: 10.12122/j.issn.1673-4254.2023.09.16.
10
Prevalence of non-diabetic renal disease in patients with type 2 diabetes.2 型糖尿病患者中非糖尿病性肾脏疾病的患病率。
Diabetes Res Clin Pract. 2010 Mar;87(3):354-9. doi: 10.1016/j.diabres.2009.11.012. Epub 2009 Dec 14.

引用本文的文献

1
Retracted: Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes.撤回:人工智能医疗机构中使用尿微量白蛋白检测糖尿病早期肾损伤的价值分析
J Healthc Eng. 2022 Nov 17;2022:9871586. doi: 10.1155/2022/9871586. eCollection 2022.
2
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway.益肾胶囊通过NOD样受体信号通路减轻糖尿病肾病症状。
Diabetes Metab Syndr Obes. 2022 Jul 26;15:2183-2195. doi: 10.2147/DMSO.S368867. eCollection 2022.
3
Development of a Risk Model for Predicting Microalbuminuria in the Chinese Population Using Machine Learning Algorithms.

本文引用的文献

1
Intelligent Diagnostic Prediction and Classification System for Chronic Kidney Disease.智能慢性肾脏病诊断预测与分类系统。
Sci Rep. 2019 Jul 3;9(1):9583. doi: 10.1038/s41598-019-46074-2.
2
Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.下调 IRAK1 通过 PI3K/Akt 信号通路减轻糖尿病肾病足细胞凋亡。
Biochem Biophys Res Commun. 2018 Nov 30;506(3):529-535. doi: 10.1016/j.bbrc.2018.09.175. Epub 2018 Oct 22.
3
Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
使用机器学习算法构建预测中国人群微量白蛋白尿的风险模型
Front Med (Lausanne). 2022 Feb 7;9:775275. doi: 10.3389/fmed.2022.775275. eCollection 2022.
WT1的尿外泌体mRNA作为糖尿病肾病的诊断和预后生物标志物
J Med Invest. 2018;65(3.4):208-215. doi: 10.2152/jmi.65.208.
4
Evaluation of KIM-1 as an early biomarker of snakebite-induced AKI in mice.评估KIM-1作为小鼠蛇咬伤诱导的急性肾损伤早期生物标志物的作用。
Toxicon. 2018 Sep 1;151:24-28. doi: 10.1016/j.toxicon.2018.06.074. Epub 2018 Jun 15.
5
Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.尿 IgG4 和 Smad1 是糖尿病肾病早期肾脏结构和功能变化的特异性生物标志物。
Diabetes. 2018 May;67(5):986-993. doi: 10.2337/db17-1043. Epub 2018 Feb 28.
6
Clinical utility of urine kidney injury molecule-1 (KIM-1) and gamma-glutamyl transferase (GGT) in the diagnosis of canine acute kidney injury.尿肾损伤分子-1(KIM-1)和γ-谷氨酰转移酶(GGT)在犬急性肾损伤诊断中的临床应用
Vet Res Commun. 2018 Jun;42(2):95-100. doi: 10.1007/s11259-018-9711-7. Epub 2018 Feb 10.
7
Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.组织中管状损伤标志物的表达与糖尿病肾病肾功能下降有关。
J Diabetes Complications. 2017 Dec;31(12):1704-1709. doi: 10.1016/j.jdiacomp.2017.08.009. Epub 2017 Aug 24.
8
NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.糖尿病肾病患者中NLRP3表达及尿HSP72与炎症和氧化应激生物标志物的关系
IUBMB Life. 2017 Aug;69(8):623-630. doi: 10.1002/iub.1645. Epub 2017 Jun 20.
9
IgG4-related nephropathy.IgG4相关性肾病
J Nephrol. 2016 Aug;29(4):487-93. doi: 10.1007/s40620-016-0279-4. Epub 2016 Mar 14.
10
Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy.尿肝型脂肪酸结合蛋白在肾病各阶段的临床意义
Indian J Nephrol. 2015 Sep-Oct;25(5):269-73. doi: 10.4103/0971-4065.145097.